Operating Lease, Payments of Edesa Biotech, Inc. from 30 Sep 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Edesa Biotech, Inc. annual and quarterly Operating Lease, Payments in USD history and change rate from 30 Sep 2023 to 30 Sep 2025.
  • Edesa Biotech, Inc. Operating Lease, Payments for the quarter ending 31 Dec 2024 was $17,885, a 11% decline year-over-year.
  • Edesa Biotech, Inc. annual Operating Lease, Payments for 2025 was $17,893, a 77% decline from 2024.
  • Edesa Biotech, Inc. annual Operating Lease, Payments for 2024 was $77,954, a 1.6% decline from 2023.
Source SEC data
View on sec.gov
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)

Edesa Biotech, Inc. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $17,893 -$60,061 -77% 01 Oct 2024 30 Sep 2025 10-K 12 Dec 2025 2025 FY
2024 $77,954 -$1,268 -1.6% 01 Oct 2023 30 Sep 2024 10-K 12 Dec 2025 2025 FY
2023 $79,222 01 Oct 2022 30 Sep 2023 10-K 13 Dec 2024 2024 FY

Edesa Biotech, Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $17,885 -$2,231 -11% 01 Oct 2024 31 Dec 2024 10-Q 14 Feb 2025 2025 Q1
Q4 2023 $20,116 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2025 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.